Novel Inflammatory Biomarkers in Cardiovascular Therapeutics

被引：1
|
作者：
Tsigkou, Vicky [1 ]
Siasos, Gerasimos [1 ]
Oikonomou, Evangelos [1 ]
Zaromitidou, Marina [1 ]
Latsios, George [1 ]
Vavuranakis, Manolis [1 ]
Deftereos, Spyridon [1 ]
Cleman, Michael W. [1 ]
Kokkou, Eleni [1 ]
Limberi, Maria [1 ]
Dimitropoulos, Stathis [1 ]
Zografos, Thodoris [1 ]
Marinaki, Smaragdi [1 ]
Stefanadis, Christodoulos [1 ,2 ]
Tousoulis, Dimitris [1 ]
机构：
[1] Univ Athens, Sch Med, Hippokrat Hosp, Dept Cardiol 1, GR-11527 Athens, Greece
[2] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA
来源：
CURRENT MEDICINAL CHEMISTRY | 2015年 / 22卷 / 23期
关键词：
Atherosclerosis; biomarkers; cardiovascular diseases; coronary artery disease; heart failure; hypertension; inflammation; peripheral artery disease; stroke; C-REACTIVE PROTEIN; PERIPHERAL ARTERIAL-DISEASE; NECROSIS-FACTOR-ALPHA; ANKLE-BRACHIAL INDEX; ACUTE MYOCARDIAL-INFARCTION; SOLUBLE ADHESION MOLECULES; BRAIN NATRIURETIC PEPTIDE; HEART-FAILURE; ATRIAL-FIBRILLATION; OXIDATIVE STRESS;
D O I：
10.2174/0929867322666150429110124
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Inflammation has been established as an important determinant of cardiovascular disease progression. Currently, clinical examination, laboratory and imaging tests are invaluable for the diagnosis, prognosis and disease monitoring. Novel inflammatory biomarkers are also used to better restratify patients in risk groups but their potential to guide treatment decisions and management of patients has not been extensively evaluated. Therefore, in this review article we present the most recent data concerning the use of inflammatory biomarkers in cardiovascular therapeutics.
引用
收藏
页码：2773 / 2785
页数：13
相关论文
共 50 条
  • [31] Inflammatory Biomarkers and Cardiovascular Risk Assessment. Current Knowledge and Future Perspectives
    Moutzouri, Elisavet
    Tsimihodimos, Vasilis
    Tselepis, Alexandros D.
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (21) : 3827 - 3840
  • [32] Inflammation and Chronic Heart Failure: From Biomarkers to Novel Anti-inflammatory Therapeutic Strategies
    Bouras, Georgios
    Giannopoulos, Georgios
    Hatzis, George
    Alexopoulos, Dimitrios
    Leventopoulos, George
    Deftereos, Spyridon
    MEDICINAL CHEMISTRY, 2014, 10 (07) : 682 - 699
  • [33] A novel peptide adropin in cardiovascular diseases
    Li, Liang
    Xie, Wei
    Zheng, Xi-Long
    Yin, Wei-Dong
    Tang, Chao-Ke
    CLINICA CHIMICA ACTA, 2016, 453 : 107 - 113
  • [34] Novel Biomarkers Assessing Renal Function in Heart Failure: Relation to Inflammatory Status and Cardiac Remodelling
    Siasos, Gerasimos
    Tousoulis, Dimitris
    Michalea, Stavroula
    Oikonomou, Evangelos
    Vavuranakis, Manolis
    Athanasiou, Dimitris
    Tourikis, Panagiotis
    Gouliopoulos, Nikolaos
    Miliou, Antigoni
    Mourouzis, Konstantinos
    Limperi, Maria
    Mazaris, Savvas
    Papavassiliou, Athanasios G.
    Stefanadis, Christodoulos
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (34) : 3976 - 3983
  • [35] Recent Advances in the Development of Cardiovascular Biomarkers
    Satoh, Kimio
    Shimokawa, Hiroaki
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (05) : E61 - E70
  • [36] Cardiovascular Biomarkers and Their Utility in the Older Adult
    Bell S.P.
    Giuseffi J.L.
    Forman D.E.
    Current Cardiovascular Risk Reports, 2012, 6 (5) : 397 - 403
  • [37] Circulating miRNAs as biomarkers in cardiovascular diseases
    Kaneto, C. M.
    Nascimento, J. S.
    Prado, M. S. J. G.
    Mendonca, L. S. O.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (05) : 2234 - 2243
  • [38] Potential novel biomarkers of cardiovascular dysfunction and disease: cardiotrophin-1, adipokines and galectin-3
    Hogas, Simona
    Bilha, Stefana C.
    Branisteanu, Dumitru
    Hogas, Mihai
    Gaipov, Abduzhappar
    Kanbay, Mehmet
    Covic, Adrian
    ARCHIVES OF MEDICAL SCIENCE, 2017, 13 (04) : 897 - 913
  • [39] Inflammatory Biomarkers for Cardiovascular Risk Stratification in Familial Hypercholesterolemia
    Bahrami, Afsane
    Liberale, Luca
    Reiner, Zeljko
    Carbone, Federico
    Montecucco, Fabrizio
    Sahebkar, Amirhossein
    REVIEWS OF PHYSIOLOGY, BIOCHEMISTRY AND PHARMACOLOGY, VOL 177, 2020, 177 : 25 - 52
  • [40] Exosome-Derived Mediators as Potential Biomarkers for Cardiovascular Diseases: A Network Approach
    Moreira-Costa, Liliana
    Barros, Antonio S.
    Lourenco, Andre P.
    Leite-Moreira, Adelino F.
    Nogueira-Ferreira, Rita
    Thongboonkerd, Visith
    Vitorino, Rui
    PROTEOMES, 2021, 9 (01) : 1 - 29
12345